MyFinsight
Home
Blog
About
Back
Income Statement
Avalyn Pharma Inc. (AVLN)
Avalyn Pharma Inc. (AVLN)
source: myfinsight.com
Interest income
$2,696K
Net loss
-$28,935K
Total other income
$2,355K
Interest expense
$272K
Other income
(expense)
-$69K
Loss from operations
-$31,290K
Total operating
expenses
$31,290K
Research and development
$24,729K
General and
administrative
$6,561K
Back